From: Biopsy of breast cancer metastases: patient characteristics and survival
Variable | P value | Adjusted OR (95.0% CI for OR) | |
---|---|---|---|
Years of metastatic recurrence | 2000–04 | Ref. | |
2005–09 | .000 | 3.79 (1.94–7.40) | |
2010–14 | .000 | 10.67 (5.13–22.22) | |
Time to recurrence(years) | <3 years | Ref. | |
> = 3 years | .000 | 3.20 (1.78–5.76) | |
Stage at initial diagnosis | Stage IIB-III | Ref. | |
Stage 0- IIA | .012 | 1.89 (1.15–3.10) | |
Site of metastasis at recurrence | No locally advanced disease | Ref. | |
Locally advanced disease | .011 | 1.90 (1.16–3.10) | |
HR &HER2 at initial diagnosis | HR+/HER2+ | Ref. | |
HR-/HER2- | .349 | 1.68 (0.57–4.93) | |
HR-/HER2+ | .813 | 1.15 (0.35–3.74) | |
HR+/HER2- | .021 | 2.83 (1.17–6.83) | |
Missing HR or/and HER2 | .000 | 6.78 (2.49–18.45) |